MCET Technologies & Veramorph won a DuPont FastPass into the Delaware Innovation Space incubator.
Each company will receive business and technology mentorship from DuPont and one year of free access to laboratories and startup support services of the Delaware Innovation Space
The DuPont FastPass competition is designed to accelerate and enhance the innovation and commercialization potential of early stage science startups.
“DuPont is fortunate to be able to partner with the local scientific and business community through programs like FastPass,” said DuPont’s Chief Technology and Sustainability Officer Alexa Dembek. “Our goal is to help accelerate the success of these talented entrepreneurs by lending our insights and capabilities in partnership with the Delaware Innovation Space.”
“The Delaware Innovation Space is excited to be combining our capabilities and expertise with DuPont, one of our foundational partners, to assist MCET and Veramorph in rapidly growing their startups,” said Bill Provine, CEO of the Delaware Innovation Space.
MCET Technologiesis a startup developing and integrating advanced sensors and electronics into conventional textiles without adding significant weight or changing the texture or feel of the fabric. MCET’s initial focus is on tracking physical rehabilitation as well as exploring new applications in sports science and training, automotive and aerospace industries, and biomedical devices.
According to David Rosenfeld, a DuPont Electronics & Imaging Technical Fellow, MCET has “developed a new material that will be interesting to explore how it fits into our current offerings and how it might allow us to extend into new application spaces.”
Veramorphis a startup that leverages an advanced proprietary hydrogel based oral drug delivery platform to help pharmaceutical companies improve the performance of their products and reduce the cost and time to bring them to market. This startup was spun out of Massachusetts Institute of Technology in 2017.
Robert Schmitt, Technical Fellow of DuPont Nutrition & Biosciences, is intrigued as “Veramorph has put together a strong team and aligned their technology to a key need within the Pharma market.” Schmitt continues, “DuPont has deep experience commercializing novel polymer solutions in this market and we can provide our historical perspective to accelerate Veramorph’s product development cycle.”